News & Updates

Show Multimedia Only

Ensifentrine improves lung function, cuts exacerbations in COPD

04 Dec 2023 by

The novel, selective, dual PDE*3 and PDE4 inhibitor ensifentrine improved lung function and reduced exacerbations in individuals with chronic obstructive pulmonary disease (COPD), findings from the ENHANCE**-1 and ENHANCE-2 trials have shown.

Ensifentrine improves lung function, cuts exacerbations in COPD

04 Dec 2023

Microcurrent therapy effective as adjunct in improving chronic ulcers

04 Dec 2023 by

The application of microcurrent across or near the site of chronic ulcers results in reduction in wound area and pain score during the treatment period.

Microcurrent therapy effective as adjunct in improving chronic ulcers

04 Dec 2023

Gastrointestinal issues linger long after COVID-19 recovery

04 Dec 2023

Gut-brain interaction disorders and persistent gastrointestinal (GI) symptoms prevail 12–18 months following COVID-19 hospitalization, and these prolonged GI issues are associated with the severity of the symptoms during hospitalization and the psychological toll of the illness experience, according to a study.

Gastrointestinal issues linger long after COVID-19 recovery

04 Dec 2023

Slow walk pace, weight gain up CKD risk in adults with obesity

03 Dec 2023

Weight gain and a slow walking pace both influence the risk of chronic kidney disease among adults with obesity who do not have diabetes at baseline, results of a study have shown.

Slow walk pace, weight gain up CKD risk in adults with obesity

03 Dec 2023

Ingestible vital sign monitor to aid in diagnosis of sleep-related respiratory disorders

02 Dec 2023 by

A wireless, capsule-like ingestible device can measure multiple vital signs from within the gastrointestinal tract, having the potential to diagnose sleep-related respiratory disorders and capture life-threatening events such as apnoea or opioid overdose, according to a study.

Ingestible vital sign monitor to aid in diagnosis of sleep-related respiratory disorders

02 Dec 2023

Fat mass, fat-free mass linked to mortality in Asians

02 Dec 2023

Asians with extremely high or low fat mass index (FMI) and fat-free mass index (FFMI) are at increased risk of mortality, suggests a study. However, the associations of FMI and FFMI with the mortality risk differ across subgroups and causes of death.

Fat mass, fat-free mass linked to mortality in Asians

02 Dec 2023

Avacopan beneficial in ANCA-related vasculitis patients on rituximab

02 Dec 2023

Avacopan, when added to background induction therapy with rituximab, is as efficacious as a prednisone taper in terms of inducing remission at week 26 and is associated with a higher rate of sustained remission at week 52 in patients with antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, according to the phase III ADVOCATE trial.

Avacopan beneficial in ANCA-related vasculitis patients on rituximab

02 Dec 2023

In utero cannabis exposure tied to adverse neonatal health outcomes

01 Dec 2023

Maternal cannabis use during pregnancy appears to contribute to increased risk of adverse neonatal health outcomes, including low birth weight (LBW) and small for gestational age (SGA), as reported in a study.

In utero cannabis exposure tied to adverse neonatal health outcomes

01 Dec 2023

SG data affirm link between elevated BP and CVD mortality among individuals with T2D

01 Dec 2023 by

Individuals with type 2 diabetes (T2D) who have high blood pressure (BP) levels are at increased risk of death from cardiovascular disease (CVD), according to a large registry cohort in Singapore. However, the risk increase is also present for those who have low diastolic BP.

SG data affirm link between elevated BP and CVD mortality among individuals with T2D

01 Dec 2023

Immunosuppression does not raise risk of overall, cancer mortality

01 Dec 2023

Use of immunosuppressants does not appear to increase the incidence of all-cause and cancer mortality in patients with noninfectious ocular inflammatory disease (OID) over a median follow-up of 10 years, a recent study has shown.

Immunosuppression does not raise risk of overall, cancer mortality

01 Dec 2023

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Ensifentrine improves lung function, cuts exacerbations in COPD

Ensifentrine improves lung function, cuts exacerbations in COPD

Microcurrent therapy effective as adjunct in improving chronic ulcers

Microcurrent therapy effective as adjunct in improving chronic ulcers

Gastrointestinal issues linger long after COVID-19 recovery

Gastrointestinal issues linger long after COVID-19 recovery

Slow walk pace, weight gain up CKD risk in adults with obesity

Slow walk pace, weight gain up CKD risk in adults with obesity

Ingestible vital sign monitor to aid in diagnosis of sleep-related respiratory disorders

Ingestible vital sign monitor to aid in diagnosis of sleep-related respiratory disorders

Fat mass, fat-free mass linked to mortality in Asians

Fat mass, fat-free mass linked to mortality in Asians

Avacopan beneficial in ANCA-related vasculitis patients on rituximab

Avacopan beneficial in ANCA-related vasculitis patients on rituximab

In utero cannabis exposure tied to adverse neonatal health outcomes

In utero cannabis exposure tied to adverse neonatal health outcomes

SG data affirm link between elevated BP and CVD mortality among individuals with T2D

SG data affirm link between elevated BP and CVD mortality among individuals with T2D

Immunosuppression does not raise risk of overall, cancer mortality

Immunosuppression does not raise risk of overall, cancer mortality